BUY Mankind Pharma Limited — Vishvesh Chauhan, ChaseAlpha

Entry₹2,545Inferred
Target₹2,640
Total upside +3.73% (call closed)
Stop loss₹2,470-2.95% risk
Exit₹2,47030 Sept 2026, 10:00 am
Stop-loss hit-2.95%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 30 Sept, 11:04 pm IST
4 supporting2 opposing
Supports the BUY call (4)

5 advisors have active short-term BUY calls on this stock, with 3 issued in the last 14 days

Advisor consensus · adjacent horizon·30 Sept · today

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·24 Sept · 5d ago

Mankind Pharma shares up 10% in just 4 sessions; Kotak upgrades the stock - Target, share price trend

NewsLivemint·22 Sept · 1w ago

(opens in new tab)

Mankind Pharma shares get an upgrade from Kotak; Price target among top five on the street

NewsCnbc-Tv18·22 Sept · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.